MedPath

LAMISIL DERMGEL

LAMISIL DERMGEL

Approved
DIN Number

02239876

Drug Class

Human

Market Date

N/A

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02239876
AIG Number0132855003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D01AE15 TERBINAFINE
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:04.08.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

TERBINAFINEActive
Strength: 10 MG / G
Monograph: TERBINAFINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.